Columbus Regional Research Institute at Talbotton — Columbus, Georgia

Columbus Regional Research Institute at Talbotton is a clinical research site located in Columbus, Georgia, United States 31904.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

Columbus Regional Research Institute at Talbotton has participated in 2 clinical trials.

Therapeutic areas: COVID-19 Disease, Gastroesophageal Reflux Disease (GERD).

Sponsors: Bavarian Nordic, Ironwood Pharmaceuticals, Inc..

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Columbus Regional Research Institute at Talbotton?

Columbus Regional Research Institute at Talbotton has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Columbus Regional Research Institute at Talbotton conducted?

Columbus Regional Research Institute at Talbotton has 2 clinical trials on record. Their work covers COVID-19 Disease, Gastroesophageal Reflux Disease (GERD).

Is Columbus Regional Research Institute at Talbotton accredited by Crixeo Health?

Columbus Regional Research Institute at Talbotton has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Columbus Regional Research Institute at Talbotton?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.